UB Paderborn / Katalog / Suche / in CDI

CTNNB1 (beta-catenin) mutation identifies low grade, early stage endometrial cancer patients at increased risk of recurrence

Modern pathology, 2017-07, Vol.30 (7), p.1032-1041

2017

Link zum Volltext

Verfügbarkeit prüfen

Immune Microenvironment in Microsatellite-Instable Endometrial Cancers: Hereditary or Sporadic Origin Matters

Clinical cancer research, 2017-08, Vol.23 (15), p.4473-4481

2017

Link zum Volltext

Verfügbarkeit prüfen

Clinical significance of CTNNB1 mutation and Wnt pathway activation in endometrioid endometrial carcinoma

JNCI : Journal of the National Cancer Institute, 2014-09, Vol.106 (9), p.1

2014

Link zum Volltext

Verfügbarkeit prüfen

Assessing PIK3CA and PTEN in Early-Phase Trials with PI3K/AKT/mTOR Inhibitors

Cell reports (Cambridge), 2014-01, Vol.6 (2), p.377-387

2014

Link zum Volltext

Verfügbarkeit prüfen

Endometrial Cancer

The New England journal of medicine, 2020-11, Vol.383 (21), p.2053-2064

2020

Link zum Volltext

Verfügbarkeit prüfen

Prospective phase II trial of levonorgestrel intrauterine device: nonsurgical approach for complex atypical hyperplasia and early-stage endometrial cancer

American journal of obstetrics and gynecology, 2021-02, Vol.224 (2), p.191.e1-191.e15

2021

Link zum Volltext

Verfügbarkeit prüfen

Targeted next-generation sequencing of endometrial cancer and matched circulating tumor DNA: identification of plasma-based, tumor-associated mutations in early stage patients

Modern pathology, 2019-03, Vol.32 (3), p.405-414

2019

Link zum Volltext

Verfügbarkeit prüfen

Concurrent fine needle aspirations and core needle biopsies: a comparative study of substrates for next-generation sequencing in solid organ malignancies

Modern pathology, 2017-04, Vol.30 (4), p.499-508

2017

Link zum Volltext

Verfügbarkeit prüfen

Regulation of inflammatory responses by IL-17F

The Journal of experimental medicine, 2008-05, Vol.205 (5), p.1063-1075

2008

Link zum Volltext

Verfügbarkeit prüfen

MIG-6 Is Critical for Progesterone Responsiveness in Human Complex Atypical Hyperplasia and Early-Stage Endometrial Cancer

International journal of molecular sciences, 2022-11, Vol.23 (23), p.14596

2022

Link zum Volltext

Verfügbarkeit prüfen

Naturally Occurring Neomorphic PIK3R1 Mutations Activate the MAPK Pathway, Dictating Therapeutic Response to MAPK Pathway Inhibitors

Cancer cell, 2014-10, Vol.26 (4), p.479-494

2014

Link zum Volltext

Verfügbarkeit prüfen

Mechanisms of mutant β-catenin in endometrial cancer progression

Frontiers in oncology, 2022-09, Vol.12, p.1009345-1009345

2022

Link zum Volltext

Verfügbarkeit prüfen

Loss of CD73-mediated actin polymerization promotes endometrial tumor progression

The Journal of clinical investigation, 2016-01, Vol.126 (1), p.220-238

2016

Link zum Volltext

Verfügbarkeit prüfen

Somatic Mutations in BRCA1 and BRCA2 Could Expand the Number of Patients That Benefit From Poly (ADP Ribose) Polymerase Inhibitors in Ovarian Cancer

Journal of clinical oncology, 2010-08, Vol.28 (22), p.3570-3576

2010

Link zum Volltext

Verfügbarkeit prüfen

Identification of Factors Affecting the Success of Next-Generation Sequencing Testing in Solid Tumors

American journal of clinical pathology, 2016-02, Vol.145 (2), p.222-237

2016

Link zum Volltext

Verfügbarkeit prüfen

High frequency of PIK3R1 and PIK3R2 mutations in endometrial cancer elucidates a novel mechanism for regulation of PTEN protein stability

Cancer discovery, 2011-07, Vol.1 (2), p.170-185

2011

Link zum Volltext

Verfügbarkeit prüfen

Clinical assessment of PTEN loss in endometrial carcinoma: immunohistochemistry outperforms gene sequencing

Modern pathology, 2012-05, Vol.25 (5), p.699-708

2012

Link zum Volltext

Verfügbarkeit prüfen

Somatic mutation profiles of clear cell endometrial tumors revealed by whole exome and targeted gene sequencing

Cancer, 2017-09, Vol.123 (17), p.3261-3268

2017

Link zum Volltext

Verfügbarkeit prüfen

Endometrial cancer and Lynch syndrome: clinical and pathologic considerations

Cancer control, 2009-01, Vol.16 (1), p.14-22

2009

Link zum Volltext

Verfügbarkeit prüfen

Centrosome-associated regulators of the G2/M checkpoint as targets for cancer therapy

Molecular cancer, 2009-02, Vol.8 (1), p.8-8, Article 8

2009

Link zum Volltext

Verfügbarkeit prüfen

KMT2D/MLL2 inactivation is associated with recurrence in adult-type granulosa cell tumors of the ovary

Nature communications, 2018-06, Vol.9 (1), p.2496-7, Article 2496

2018

Link zum Volltext

Verfügbarkeit prüfen

A Targeted High-Throughput Next-Generation Sequencing Panel for Clinical Screening of Mutations, Gene Amplifications, and Fusions in Solid Tumors

The Journal of molecular diagnostics : JMD, 2017-03, Vol.19 (2), p.255-264

2017

Link zum Volltext

Verfügbarkeit prüfen

Restoration of miR-200c to ovarian cancer reduces tumor burden and increases sensitivity to paclitaxel

Molecular cancer therapeutics, 2012-12, Vol.11 (12), p.2556-2565

2012

Link zum Volltext

Verfügbarkeit prüfen

Carcinoma of the Lower Uterine Segment: A Newly Described Association With Lynch Syndrome

Journal of clinical oncology, 2008-12, Vol.26 (36), p.5965-5971

2008

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

CTNNB1 (beta-catenin) mutation identifies low grade, early stage endometrial cancer patients at increased risk of recurrence

Immune Microenvironment in Microsatellite-Instable Endometrial Cancers: Hereditary or Sporadic Origin Matters

Clinical significance of CTNNB1 mutation and Wnt pathway activation in endometrioid endometrial carcinoma

Assessing PIK3CA and PTEN in Early-Phase Trials with PI3K/AKT/mTOR Inhibitors

Endometrial Cancer

Opposing effects of cancer-type-specific SPOP mutants on BET protein degradation and sensitivity to BET inhibitors

Prospective phase II trial of levonorgestrel intrauterine device: nonsurgical approach for complex atypical hyperplasia and early-stage endometrial cancer

Targeted next-generation sequencing of endometrial cancer and matched circulating tumor DNA: identification of plasma-based, tumor-associated mutations in early stage patients

Concurrent fine needle aspirations and core needle biopsies: a comparative study of substrates for next-generation sequencing in solid organ malignancies

Regulation of inflammatory responses by IL-17F

MIG-6 Is Critical for Progesterone Responsiveness in Human Complex Atypical Hyperplasia and Early-Stage Endometrial Cancer

Naturally Occurring Neomorphic PIK3R1 Mutations Activate the MAPK Pathway, Dictating Therapeutic Response to MAPK Pathway Inhibitors

Mechanisms of mutant β-catenin in endometrial cancer progression

Loss of CD73-mediated actin polymerization promotes endometrial tumor progression

Somatic Mutations in BRCA1 and BRCA2 Could Expand the Number of Patients That Benefit From Poly (ADP Ribose) Polymerase Inhibitors in Ovarian Cancer

Identification of Factors Affecting the Success of Next-Generation Sequencing Testing in Solid Tumors

High frequency of PIK3R1 and PIK3R2 mutations in endometrial cancer elucidates a novel mechanism for regulation of PTEN protein stability

Clinical assessment of PTEN loss in endometrial carcinoma: immunohistochemistry outperforms gene sequencing

Somatic mutation profiles of clear cell endometrial tumors revealed by whole exome and targeted gene sequencing

Endometrial cancer and Lynch syndrome: clinical and pathologic considerations

Centrosome-associated regulators of the G2/M checkpoint as targets for cancer therapy

KMT2D/MLL2 inactivation is associated with recurrence in adult-type granulosa cell tumors of the ovary

A Targeted High-Throughput Next-Generation Sequencing Panel for Clinical Screening of Mutations, Gene Amplifications, and Fusions in Solid Tumors

Restoration of miR-200c to ovarian cancer reduces tumor burden and increases sensitivity to paclitaxel

Carcinoma of the Lower Uterine Segment: A Newly Described Association With Lynch Syndrome

Suchergebnisse filtern